• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Galena Biopharma Inc

+ Add to Watchlist

RXK:GR

2.200 EUR 0.010 0.46%

As of 09:53:28 ET on 07/23/2014.

Snapshot for Galena Biopharma Inc (RXK)

Open: 2.006 Day's Range: 2.006 - 2.232 Volume: 2,600
Previous Close: 2.190 52wk Range: 1.110 - 5.706 1-Yr Rtn: +61.65%

Stock Chart for RXK

No chart data available.
  • RXK:GR 2.200
  • 1D
  • 1M
  • 1Y
2.190
Interactive RXK Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for RXK

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -0.3010
Est. PEG Ratio -
Market Cap (M EUR) 259.66
Shares Outstanding (M) 118.03
30 Day Average Volume 1,769
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/08/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for RXK

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for RXK

Galena Biopharma, Inc. is a biopharmaceuticals company that develops late-stage oncology drugs. The Company develops therapies that activate cells in the immune system to seek out and eliminate tumor cells without harming healthy tissue.

Mark J AhnPresident/CEOMark W SchwartzExec VP/COO
Brian L HamiltonExec VP/Chief Medical OfficerRyan M DunlapVP/CFO/Secretary
More Company Profile & Key Executives for RXK

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil